The Food Allergy Fund (FAF) today convened scientists, investors, policymakers, and advocates at its annual Summit in New ...
Hosted on MSN
Every Cure’s drug repurposing strategy isn't what you think, and it could change rare disease treatment
Every Cure is using AI to seek new uses for the roughly 4,000 existing drugs, and cutting traditional preliminary research timelines from as much as 100 days to as little as 17 hours. Treatment for a ...
The rapid emergence of antimicrobial resistance (AMR) and zoonotic pathogens underscores the urgent need for innovative, interdisciplinary strategies to ...
PUNE, MAHARASHTRA, INDIA, March 17, 2026 /EINPresswire.com/ — Solix Technologies and Symbiosis Center for Entrepreneurship & Innovation in collaboration with ...
The need for medical treatments for rare diseases such as Leigh syndrome is high. However, low patient numbers make research ...
Drug repurposing could help find a treatment for multiple sulfatase deficiency, a rare genetic disease that currently has no ...
Researchers from Germany and Luxembourg have used AI and brain organoid models to identify two existing drugs, talarozole and sertaconazole, as potential treatments for Leigh syndrome. The approach ...
With the help of artificial intelligence, a coalition of Bay Area institutions identified 18 FDA-approved drugs that could improve the lives of those suffering from amyotrophic lateral sclerosis, ...
This Perspective reviews how AI is moving drug discovery from long, costly experimental pipelines toward earlier clinical translation, with an AI-designed TNIK inhibitor trial serving as an important ...
OpenAI Foundation pledges $100 million to Alzheimer’s research, highlighting AI’s potential to accelerate diagnosis, drug ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results